Rare lephants
Screener

Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 7, 2025 FORM 4
4 Jan 7, 2025 FORM 4
4 Jan 7, 2025 FORM 4
4 Jan 7, 2025 FORM 4
4 Jan 7, 2025 FORM 4
4 Jan 7, 2025 FORM 4
4 Jan 7, 2025 FORM 4
144 Jan 3, 2025
144 Jan 3, 2025
144 Jan 3, 2025
144 Jan 3, 2025
144 Jan 3, 2025
10-Q Nov 12, 2024 10-Q
8-K Nov 12, 2024 8-K
4 Nov 6, 2024 4
3 Nov 6, 2024 3
10-Q Aug 13, 2024 10-Q
8-K Aug 13, 2024 8-K
4 Jun 10, 2024
4 Jun 10, 2024 FORM 4
4 Jun 10, 2024 FORM 4
4 Jun 10, 2024 FORM 4
4 Jun 10, 2024 FORM 4
4 Jun 10, 2024 FORM 4
4 Jun 10, 2024 FORM 4
← Newer Page 7 of 15 · 365 filings Older →